0001493152-21-016652.txt : 20210712
0001493152-21-016652.hdr.sgml : 20210712
20210712171131
ACCESSION NUMBER: 0001493152-21-016652
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210712
FILED AS OF DATE: 20210712
DATE AS OF CHANGE: 20210712
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gupta Pramod
CENTRAL INDEX KEY: 0001857927
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40582
FILM NUMBER: 211086148
MAIL ADDRESS:
STREET 1: UNICYCIVE THERAPEUTICS, INC.
STREET 2: 5150 EL CAMINO REAL, SUITE A-32
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001766140
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813638692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5150 EL CAMINO REAL, SUITE A-32
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
BUSINESS PHONE: 650-384-0642
MAIL ADDRESS:
STREET 1: 5150 EL CAMINO REAL, SUITE A-32
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
3
1
ownership.xml
X0206
3
2021-07-12
0
0001766140
Unicycive Therapeutics, Inc.
UNCY
0001857927
Gupta Pramod
C/O UNICYCIVE THERAPEUTICS, INC.
5150 EL CAMINO REAL SUITE A-32
LOS ALTOS
CA
94022
0
1
0
0
EVP, Pharma and Business Ops
Employee Stock Option (right to buy)
3.27
2029-10-01
Common Stock
52326
D
Employee Stock Option (right to buy)
3.27
2029-12-30
Common Stock
23256
D
Employee Stock Option (right to buy)
3.27
2030-04-06
Common Stock
58140
D
Employee Stock Option (right to buy)
7.01
2031-03-01
Common Stock
23256
D
Twenty-five percent (25%) of the stock options vested on October 1, 2020, and the remaining seventy-five percent (75%) of the stock options have vested and will continue to vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on October 1, 2023.
Twenty-five percent (25%) of the stock options vested on January 1, 2021, and the remaining seventy-five percent (75%) of the stock options have vested and will continue to vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on January 1, 2024.
Twenty-five percent (25%) of the stock options vested on April 6, 2021, and the remaining seventy-five percent (75%) of the stock options have vested and will continue to vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on April 6, 2024.
Twenty-five percent (25%) of the stock options vest on March 1, 2022, and the remaining seventy-five percent (75%) of the stock options vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on March 1, 2025.
/s/ Pramod Gupta
2021-07-12